Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors

Devon D. Brewer, Holly Hagan, Daniel G. Sullivan, Stephen Q. Muth, Eileen S. Hough, Nathan A. Feuerborn, David R. Gretch

Research output: Contribution to journalArticle

Abstract

Background. Hepatitis C virus (HCV) is hyperendemic in drug injectors, yet social structural and behavioral factors underlying transmission are not well established. Methods. We conducted a case-control study of HCV seroconversion in drug injectors, focusing on transmission within networks. Incident case subjects (n = 17) and seronegative control subjects (n = 42) reported injection and sex partners and referred as many as 5 for interviewing and blood testing. We performed nucleotide sequencing of HCV isolates from infected individuals. Results. Seventy-eight percent of recent injection partnerships involved behavior that could transmit HCV. Case subjects and control subjects were similar demographically and behaviorally. Case subjects, however, had more HCV-infected partners and consequently engaged in injection risk behavior with more infected partners. The injection network was mostly connected, dense, and cyclic, but the sexual network was highly fragmented. Although participants generally injected with partners of similar age, most HCV-uninfected participants recently had injected with infected partners. In at least 1 of 4 pairs of genetically linked infections, transmission appeared to be due to sharing of injection equipment other than syringes. Except for transmission pairs, network distance between incident case subjects and genetic distance between their HCV variants were uncorrelated. Conclusions. Without dramatic reductions in injection risk behaviors, shattering of cohesive injection networks, and/or broad coverage of an effective vaccine, HCV will likely remain hyperendemic in drug injectors.

Original languageEnglish (US)
Pages (from-to)764-772
Number of pages9
JournalJournal of Infectious Diseases
Volume194
Issue number6
DOIs
StatePublished - Sep 15 2006

Fingerprint

Hepacivirus
Injections
Pharmaceutical Preparations
Risk-Taking
Infectious Disease Transmission
Syringes
Case-Control Studies
Vaccines
Nucleotides
Equipment and Supplies

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Brewer, D. D., Hagan, H., Sullivan, D. G., Muth, S. Q., Hough, E. S., Feuerborn, N. A., & Gretch, D. R. (2006). Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. Journal of Infectious Diseases, 194(6), 764-772. https://doi.org/10.1086/505585

Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. / Brewer, Devon D.; Hagan, Holly; Sullivan, Daniel G.; Muth, Stephen Q.; Hough, Eileen S.; Feuerborn, Nathan A.; Gretch, David R.

In: Journal of Infectious Diseases, Vol. 194, No. 6, 15.09.2006, p. 764-772.

Research output: Contribution to journalArticle

Brewer, Devon D. ; Hagan, Holly ; Sullivan, Daniel G. ; Muth, Stephen Q. ; Hough, Eileen S. ; Feuerborn, Nathan A. ; Gretch, David R. / Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. In: Journal of Infectious Diseases. 2006 ; Vol. 194, No. 6. pp. 764-772.
@article{deeb7782ad124396933479196869e7ed,
title = "Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors",
abstract = "Background. Hepatitis C virus (HCV) is hyperendemic in drug injectors, yet social structural and behavioral factors underlying transmission are not well established. Methods. We conducted a case-control study of HCV seroconversion in drug injectors, focusing on transmission within networks. Incident case subjects (n = 17) and seronegative control subjects (n = 42) reported injection and sex partners and referred as many as 5 for interviewing and blood testing. We performed nucleotide sequencing of HCV isolates from infected individuals. Results. Seventy-eight percent of recent injection partnerships involved behavior that could transmit HCV. Case subjects and control subjects were similar demographically and behaviorally. Case subjects, however, had more HCV-infected partners and consequently engaged in injection risk behavior with more infected partners. The injection network was mostly connected, dense, and cyclic, but the sexual network was highly fragmented. Although participants generally injected with partners of similar age, most HCV-uninfected participants recently had injected with infected partners. In at least 1 of 4 pairs of genetically linked infections, transmission appeared to be due to sharing of injection equipment other than syringes. Except for transmission pairs, network distance between incident case subjects and genetic distance between their HCV variants were uncorrelated. Conclusions. Without dramatic reductions in injection risk behaviors, shattering of cohesive injection networks, and/or broad coverage of an effective vaccine, HCV will likely remain hyperendemic in drug injectors.",
author = "Brewer, {Devon D.} and Holly Hagan and Sullivan, {Daniel G.} and Muth, {Stephen Q.} and Hough, {Eileen S.} and Feuerborn, {Nathan A.} and Gretch, {David R.}",
year = "2006",
month = "9",
day = "15",
doi = "10.1086/505585",
language = "English (US)",
volume = "194",
pages = "764--772",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors

AU - Brewer, Devon D.

AU - Hagan, Holly

AU - Sullivan, Daniel G.

AU - Muth, Stephen Q.

AU - Hough, Eileen S.

AU - Feuerborn, Nathan A.

AU - Gretch, David R.

PY - 2006/9/15

Y1 - 2006/9/15

N2 - Background. Hepatitis C virus (HCV) is hyperendemic in drug injectors, yet social structural and behavioral factors underlying transmission are not well established. Methods. We conducted a case-control study of HCV seroconversion in drug injectors, focusing on transmission within networks. Incident case subjects (n = 17) and seronegative control subjects (n = 42) reported injection and sex partners and referred as many as 5 for interviewing and blood testing. We performed nucleotide sequencing of HCV isolates from infected individuals. Results. Seventy-eight percent of recent injection partnerships involved behavior that could transmit HCV. Case subjects and control subjects were similar demographically and behaviorally. Case subjects, however, had more HCV-infected partners and consequently engaged in injection risk behavior with more infected partners. The injection network was mostly connected, dense, and cyclic, but the sexual network was highly fragmented. Although participants generally injected with partners of similar age, most HCV-uninfected participants recently had injected with infected partners. In at least 1 of 4 pairs of genetically linked infections, transmission appeared to be due to sharing of injection equipment other than syringes. Except for transmission pairs, network distance between incident case subjects and genetic distance between their HCV variants were uncorrelated. Conclusions. Without dramatic reductions in injection risk behaviors, shattering of cohesive injection networks, and/or broad coverage of an effective vaccine, HCV will likely remain hyperendemic in drug injectors.

AB - Background. Hepatitis C virus (HCV) is hyperendemic in drug injectors, yet social structural and behavioral factors underlying transmission are not well established. Methods. We conducted a case-control study of HCV seroconversion in drug injectors, focusing on transmission within networks. Incident case subjects (n = 17) and seronegative control subjects (n = 42) reported injection and sex partners and referred as many as 5 for interviewing and blood testing. We performed nucleotide sequencing of HCV isolates from infected individuals. Results. Seventy-eight percent of recent injection partnerships involved behavior that could transmit HCV. Case subjects and control subjects were similar demographically and behaviorally. Case subjects, however, had more HCV-infected partners and consequently engaged in injection risk behavior with more infected partners. The injection network was mostly connected, dense, and cyclic, but the sexual network was highly fragmented. Although participants generally injected with partners of similar age, most HCV-uninfected participants recently had injected with infected partners. In at least 1 of 4 pairs of genetically linked infections, transmission appeared to be due to sharing of injection equipment other than syringes. Except for transmission pairs, network distance between incident case subjects and genetic distance between their HCV variants were uncorrelated. Conclusions. Without dramatic reductions in injection risk behaviors, shattering of cohesive injection networks, and/or broad coverage of an effective vaccine, HCV will likely remain hyperendemic in drug injectors.

UR - http://www.scopus.com/inward/record.url?scp=33748419915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748419915&partnerID=8YFLogxK

U2 - 10.1086/505585

DO - 10.1086/505585

M3 - Article

VL - 194

SP - 764

EP - 772

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -